Twitter | Search | |
Search Refresh
Okomeds Jun 11
Anticoagulants are substances usually known as blood thinners, that is, substances used to prevent the formation of blood clots.
Reply Retweet Like
Susan Trevillian (nee Parry) Jun 13
...approximately two-thirds of Victorian patients at risk of were not supplied oral within 30 days of discharge, almost half of Victorian patients at risk of AMI were not supplied therapies within 30 days of discharge.
Reply Retweet Like
Infermiere On Line Jun 10
Reversing Direct Oral in Acute Intracranial Hemorrhage |
Reply Retweet Like
Aliro Consulting Jun 14
Effects of in With and Vein Thrombosis: A Systematic Review and Meta-analysis
Reply Retweet Like
OUH Research Jun 13
Congratulations to consultant Dr Susie Shapiro for her award for developing a service in to improve the prescribing of
Reply Retweet Like
Pharmacy Daily Jun 12
at high risk of & are being discharged from Vic without : budget cuts SHPA - The Society of Hospital Pharmacists of Australia via Pharmacy Daily
Reply Retweet Like
Emma Wood Jan 21
Fantastic summary of looking after our complex older patients on at optimising anticoagulation therapy study day from Dr Clifford Lisk
Reply Retweet Like
JAMA 19 May 18
This JAMA Clinical Guidelines Synopsis summarizes the (ACC) Foundation’s 2017 consensus guideline on management of bleeding in patients taking oral .
Reply Retweet Like
Anneka Mitchell Apr 24
The first publication of my ⁦⁩ funded PhD is now online! 😃 A systematic review of in people with ⁩ ⁦⁩ ⁦
Reply Retweet Like
Roopen Arya May 1
Excellent grand round by lead pharmacist Roz Byrne & Resp Med consultant Jimstan Periselneris on measures we’ve taken to ensure patients on are safely followed up. ⁦⁩ ⁦⁦⁩ ⁦
Reply Retweet Like
Matteo Cesari Apr 26
I would invite those specialists easily prescribing the novel oral to frail older persons to visit a geriatric unit and have a look at the consequences... Never seen so many iatrogenic bleedings with ...
Reply Retweet Like
Anneka Mitchell Feb 8
Come see me at and talk about my work on use of in or about my fab research training fellowship from who are making this research possible
Reply Retweet Like
manuel monreal 29 Dec 17
, not inferior to standard in patients with contraindications to be recruited in randomized trials. Data from registry.
Reply Retweet Like
Jane Starr Aug 16
New doctor prescribing support training by Variety of speakers and topics based on high risk meds- burden and falls risk . Great interaction and engagement!@ESHT_ESME
Reply Retweet Like
Samer Narouze,MD,PhD Feb 18
I was surprised to learn that some don’t stop prior to lumbar injection. 👇🏼is our response The risk of with transforaminals. What do you do? Rationale?⁦⁩ ⁦
Reply Retweet Like
Vincent Ⓜ️israi 28 Sep 17
Finally! Ready to launch inclusions of this promising 🇫🇷 RCT
Reply Retweet Like
ThrombosisTV 27 Oct 17
Reply Retweet Like
European Society of Cardiology 27 Aug 16
New oral provide same prevention as warfarin but cause less bleeding
Reply Retweet Like
Leslie Deane MBBS, MS, FRCSC, FACS Oct 22
Very practical insights into the perioperative management of at
Reply Retweet Like
IATDMCT 19 May 17
Ready for ❓Idarucizumab is an ! 💉Which of these is concerned?
Reply Retweet Like